Digg
Del.icio.us
Newsvine 
Facebook
StumbleuponJapan's Taisho Pharmaceutical Co. Ltd. said Wednesday it will buy Bristol-Myers Squibb Co.'s over-the-counter drug assets worth US$310 million in Asia Pacific (excluding China and Japan).
Under their agreement, Taisho will acquire from Bristol-Myers Squibb certain product registrations, trademarks and related assets of selected pharmaceutical and over-the-counter products sold primarily in Indonesia, Thailand and The Philippines, as well as in other countries in the Asia Pacific region.
Japan's largest maker of OTC pharmaceutical products by sales said it will buy the New York-based drug maker's OTC brand assets in the region for US$160 million.
The transaction also includes Bristol-Myers Squibb's 97.97 per cent stake in PT Bristol-Myers Squibb Indonesia Tbk. Taisho said it hopes to use to the Indonesian firm's production facilities and sales network to expand into Asia.
The closing of the transaction is expected to occur during the fourth quarter of 2009.
The one-time fiancée of cricketer Michael Clarke underwent a screen test for a job as an entertainment reporter at Bigpond TV. Unfortunately for ...
Continuing a trend in Queensland's residential property market, the number of sales of units and townhouses reduced markedly during the tail end ...
Two Australian school teachers from Warwick State High School have become the subject of controversy after posting raunchy photos of themselves i...
© 2010 The Ibtimes Company. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
